Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron T Gerds

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Hematology. American Society of Hematology. Education Program|February 20, 2015
Established and novel agents for myelodysplastic syndromesMikkael A Sekeres, Aaron T Gerds
Blood|January 14, 2025
How I treat anemia in myelofibrosisAkriti G Jain, Aaron T Gerds
Leukemia & Lymphoma|July 10, 2015
Time, timing, and the treatment of diffuse large B-cell lymphomaAaron T Gerds, Mikkael A Sekeres
Current Opinion in Hematology|January 10, 2012
Transplantation for myelodysplastic syndrome in the era of hypomethylating agentsAaron T Gerds, H Joachim Deeg
Clinical Advances in Hematology & Oncology : H&O|November 29, 2012
To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decisionAaron T Gerds, Frederick R Appelbaum
Best Practice & Research. Clinical Haematology|April 1, 2019
Can allogeneic hematopoietic cell transplant cure therapy-related acute leukemia?Yazan F Madanat, Aaron T Gerds
Leukemia & Lymphoma|April 24, 2015
Albumin as a prognostic marker in myelodysplastic syndromes: still relevant after all these yearsAaron T Gerds, Mikkael A Sekeres
Cancer|May 1, 2015
The graceful exit or reluctant demise of the older adult with acute myeloid leukemiaMikkael A Sekeres, Aaron T Gerds
Leukemia & Lymphoma|February 25, 2014
Initial transfusion frequency and survival in myelodysplastic syndromes: hopping onto a fast train to nowhereAaron T Gerds, Mikkael A Sekeres
Seminars in Hematology|June 27, 2015
Mitigating Fear and Loathing in Managing Acute Myeloid LeukemiaMikkael A Sekeres, Aaron T Gerds
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Hematology. American Society of Hematology. Education Program|February 20, 2015
Established and novel agents for myelodysplastic syndromesMikkael A Sekeres, Aaron T Gerds
Blood|January 14, 2025
How I treat anemia in myelofibrosisAkriti G Jain, Aaron T Gerds
Leukemia & Lymphoma|July 10, 2015
Time, timing, and the treatment of diffuse large B-cell lymphomaAaron T Gerds, Mikkael A Sekeres
Current Opinion in Hematology|January 10, 2012
Transplantation for myelodysplastic syndrome in the era of hypomethylating agentsAaron T Gerds, H Joachim Deeg
Clinical Advances in Hematology & Oncology : H&O|November 29, 2012
To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decisionAaron T Gerds, Frederick R Appelbaum
Best Practice & Research. Clinical Haematology|April 1, 2019
Can allogeneic hematopoietic cell transplant cure therapy-related acute leukemia?Yazan F Madanat, Aaron T Gerds
Leukemia & Lymphoma|April 24, 2015
Albumin as a prognostic marker in myelodysplastic syndromes: still relevant after all these yearsAaron T Gerds, Mikkael A Sekeres
Cancer|May 1, 2015
The graceful exit or reluctant demise of the older adult with acute myeloid leukemiaMikkael A Sekeres, Aaron T Gerds
Leukemia & Lymphoma|February 25, 2014
Initial transfusion frequency and survival in myelodysplastic syndromes: hopping onto a fast train to nowhereAaron T Gerds, Mikkael A Sekeres
Seminars in Hematology|June 27, 2015
Mitigating Fear and Loathing in Managing Acute Myeloid LeukemiaMikkael A Sekeres, Aaron T Gerds
Pageof 14